Previous reports suggested that culture as 3D aggregates or as spheroids can increase the therapeutic potential of the adult stem/progenitor cells referred to as mesenchymal stem cells or multipotent mesenchymal stromal cells (MSCs). Here we used a hanging drop protocol to prepare human MSCs (hMSCs) as spheroids that maximally expressed TNFα stimulated gene/protein 6 (TSG-6), the antiinflammatory protein that was expressed at high levels by hMSCs trapped in the lung after i.v. infusion and that largely explained the beneficial effects of hMSCs in mice with myocardial infarcts. The properties of spheroid hMSCs were found to depend critically on the culture conditions. Under optimal conditions for expression of TSG-6, the hMSCs also expressed high levels of stanniocalcin-1, a protein with both antiinflammatory and antiapoptotic properties. In addition, they expressed high levels of three anticancer proteins: IL-24, TNFα-related apoptosis inducing ligand, and CD82. The spheroid hMSCs were more effective than hMSCs from adherent monolayer cultures in suppressing inflammatory responses in a coculture system with LPS-activated macrophages and in a mouse model for peritonitis. In addition, the spheroid hMSCs were about one-fourth the volume of hMSCs from adherent cultures. Apparently as a result, larger numbers of the cells trafficked through the lung after i.v. infusion and were recovered in spleen, liver, kidney, and heart. The data suggest that spheroid hMSCs may be more effective than hMSCs from adherent cultures in therapies for diseases characterized by sterile tissue injury and unresolved inflammation and for some cancers that are sensitive to antiinflammatory agents. 
Previous reports suggested that culture as 3D aggregates or as spheroids can increase the therapeutic potential of the adult stem/progenitor cells referred to as mesenchymal stem cells or multipotent mesenchymal stromal cells (MSCs). Here we used a hanging drop protocol to prepare human MSCs (hMSCs) as spheroids that maximally expressed TNFα stimulated gene/protein 6 (TSG-6), the antiinflammatory protein that was expressed at high levels by hMSCs trapped in the lung after i.v. infusion and that largely explained the beneficial effects of hMSCs in mice with myocardial infarcts. The properties of spheroid hMSCs were found to depend critically on the culture conditions. Under optimal conditions for expression of TSG-6, the hMSCs also expressed high levels of stanniocalcin-1, a protein with both antiinflammatory and antiapoptotic properties. In addition, they expressed high levels of three anticancer proteins: IL-24, TNFα-related apoptosis inducing ligand, and CD82. The spheroid hMSCs were more effective than hMSCs from adherent monolayer cultures in suppressing inflammatory responses in a coculture system with LPS-activated macrophages and in a mouse model for peritonitis. In addition, the spheroid hMSCs were about one-fourth the volume of hMSCs from adherent cultures. Apparently as a result, larger numbers of the cells trafficked through the lung after i.v. infusion and were recovered in spleen, liver, kidney, and heart. The data suggest that spheroid hMSCs may be more effective than hMSCs from adherent cultures in therapies for diseases characterized by sterile tissue injury and unresolved inflammation and for some cancers that are sensitive to antiinflammatory agents.
inflammation | MSC | stanniocalcin-1 | spheroid | TNFα stimulated gene/ protein 6 T here has been considerable interest in the therapeutic potentials of the cells from bone marrow referred to initially as colony forming units-fibroblastic, then as marrow stromal cells, subsequently as mesechymal stem cells, and most recently as multipotent mesenchymal stromal cells (MSCs) (1) (2) (3) (4) (5) (6) . The cells are relatively easy to isolate from human donors or patients, expand rapidly for 30 or more population doublings in culture, and differentiate into several cellular phenotypes in vitro and in vivo. These and related properties prompted testing the therapeutic potential of the cells in animal models and in clinical trials for a large number of diseases (see www.clinicaltrials.gov). The initial assumption in exploring the therapeutic benefits of MSCs was that they might engraft and differentiate to replace injured cells. Engraftment and differentiation was observed in rapidly grown embryos, with extreme tissue injury, or after local administrations of large concentrations of the cells. Frequently, however, therapeutic benefits were observed without evidence of engraftment. Instead, the cells enhanced tissue repair or limited tissue destruction by paracrine secretions or cell-to-cell contacts that modulated inflammatory or immune reactions (3, (6) (7) (8) . The potential paracrine effects of the cells was suggested by the observations that the cells in culture secrete a large number of cytokines (9, 10) . Recent reports, however, have demonstrated that MSCs are activated by cross-talk with injured cells to express high levels of a large number of additional genes (9, (11) (12) (13) (14) (15) .
We previously observed (14) that i.v.-infused human MSCs (hMSCs) improved cardiac function and decreased scarring in a mouse model of myocardial infarction in part because the cells that were trapped in the lung as microemboli were activated to secrete the antiinflammatory protein TNFα stimulated gene/protein 6 (TSG-6) (16) . The TSG-6 decreased the inflammatory reactions in the heart and thereby limited deterioration of the cardiac tissue. However, the hMSCs did not express TSG-6 until 12-24 h after they created microemboli in lungs and until about half the hMSCs had undergone destruction through apoptosis and necrosis. We also observed that standard cultures of hMSCs did not express TSG-6 but were activated to express the protein if incubated for 24 h or longer with the inflammatory cytokine TNFα (14) .
The observations suggested that appropriate manipulation of hMSCs in culture before in vivo administration might enhance their therapeutic benefits by eliminating the lag period for activation on the cells by signals from injured tissues.
Recently there has been a series of publications on aggregation of MSCs either as a procedure for enhancing chrondrogenic differentiation of the cells (17) (18) (19) or to increase their therapeutic potential (20-23). Because aggregated hMSCs were detected in the pulmonary microemboli observed after i.v. infusion of the cells (14, 24) , we tested the hypothesis that aggregation of hMSCs in culture may provide an effective procedure to preactivate the cells to express TSG-6, and thereby, enhance their antiinflammatory effects through a reduction in the lag period for expression of the gene in vivo.
Results
Aggregation of hMSCs in Hanging Drops into Spheroids. To aggregate hMSCs, we used a hanging drop protocol. Time-lapse microscopy demonstrated that hMSCs cultured in hanging drops first formed a loose network and then numerous small aggregates that gradually coalesced into a single central spheroid along the lower surface of the drop (Fig. 1A) . Once assembled, the spheroid did not increase in size but progressively compacted between 48 and 96 h. H&E staining of sections revealed the spheroids were solid throughout with small round cells evenly distributed and embedded in matrix (Fig. 1B) . The surface of the spheroid had a layer of epithelium-like cells that were more elongated and flatter. As expected, the sizes of the spheroids were dependent on the number of hMSCs suspended in the hanging drops (Fig. 1E) . hMSC spheroids of all sizes expressed and secreted very high levels of the antiinflammatory molecule TSG-6 compared with either low or high density monolayer cultures, but spheroids of 25,000 cells (Sph 25k) showed the highest expression and secretion of TSG-6 ( Fig. 1 C and D) . Moreover, TSG-6 expression increased in a time dependent manner with spheroids of 25,000 hMSCs and was consistently much higher than in standard cultures of adherent hMSCs (Fig. 1F) .
Viability of hMSCs in Spheroids. Because hMSCs in spheroids may have less access to nutrients, it was of interest to establish whether the cells remained viable. In 3-d cultures of spheroids of 10,000 or 25,000 hMSCs, almost 90% of the harvested cells were viable as assayed by propidium iodide (PI) uptake and labeling with annexin V-FITC ( Fig. 2A) . The number of apoptotic or necrotic cells was greater in spheroids prepared with 100,000 or 250,000 hMSCs ( Fig. 2A) . Also, the number of apoptotic or necrotic cells increased slightly when the incubation period was extended from 3 d to 4 d (Fig. 2B) .
Analysis of Spheroid hMSC Size in Vitro and Relative Tissue Distribution
After i.v. Infusion. As suggested by histological sections (Fig. 1B) , hMSCs in spheroids appeared smaller than hMSCs from standard monolayer cultures. The cells released from spheroids by trypsinization were nearly half the diameter and approximately one-fourth the volume of hMSCs derived from adherent monolayers as shown by flow cytometry (Fig. 3A and Fig. S1 ) and microscopy ( Fig. 3B) .
To test if the smaller size of the hMSCs dissociated from spheroids would allow the cells to traffic through the lung microvasculature and therefore distribute more efficiently into other tissues, both monolayer and spheroid hMSCs were injected i.v. into the tail vein of NOD/scid mice. Real-time PCR for human Alu sequences in the lungs collected 15 min after hMSC infusion suggested that the number of trapped cells decreased by about 25% with spheroidderived hMSCs compared with monolayer hMSCs, At the same time, a larger fraction of infused spheroid hMSCs were recovered in the liver, spleen, kidney, and heart (Fig. 3C ).
hMSCs Dissociated from Spheroids Retain the Properties of Adherent hMSCs. hMSCs dissociated from spheroids retained the ability to differentiate into mineralizing cells and adipocytes (Fig. 4 A and B) . The dissociated cells expanded more slowly during an initial passage and then more rapidly than adherent hMSCs through four passages before reaching senescence at about the same number of population doublings (Fig. 4C and Fig. S2A ). In addition, the dissociated cells readily generated colonies (CFUs) when plated at clonal densities (Fig. 4D and Fig. S2B ). Consistent with the data on rates of propagation (Fig. 4C) , the number of CFUs from spheroid cells was initially less than the number of CFUs from adherent cultures but was greater in later passages ( Fig. 4D and Fig. S2B ). The surface epitopes of the hMSCS dissociated from spheroids were similar to the surface epitopes of hMSCs from adherent monolayers when dissociated under the same conditions with trypsin (10 min at 37°C): the dissociated cells were negative for hematopoietic markers, and they were slightly less positive for CD73, CD90, and CD105, apparently because of the smaller size of the cells (Fig. 4E, Figs . S3-S6, and Table S1 ).
Transcriptome Changes in the Spheroid hMSCs. Surveys with microarray assays demonstrated that 236 genes were up-regulated and 230 genes were down-regulated in a comparison of spheroid cells with hMSCs from adherent monolayers ( Fig. 5A and Table S2 ). There were increases in genes with ontologies for extracellular region, regulation of cell adhesion, receptor binding, cell communication, extracellular matrix, and negative regulation of cell proliferation (Fig. 5A) . Also, there were parallel decreases in genes with ontologies for cytoskeleton organization and biogenesis, mitosis, cell cycle, and extracellular matrix (Fig. 5A ). Of special interest was the increase in genes with ontologies for response to wounding and inflammatory response (Fig. 5A) . Real time RT PCR assays (Fig. 6A ) demonstrated marked increases in the expression of TSG-6; stanniocalcin-1 (STC-1), an antiinflammatory/antiapoptotic protein; leukemia inhibitory factor (LIF), a cytokine for growth and development; IL-24, a tumor suppressor protein; TNFα-related apoptosis inducing ligand (TRAIL), a protein with selectivity for killing certain cancer cells; and CXC chemokine receptor 4 (CXCR4), a receptor involved in MSC homing. As expected from its stimulatory effect of MSC proliferation (25), there was decreased expression of dickkopf 1 (DKK1), an inhibitor of Wnt signaling (Fig. 6A) . (Figs. S3-S6 ). There was partial down-regulation of the melanoma cell adhesion molecule (MCAM or CD146) that is used as a marker for endothelial cells and pericytes, and of ALCAM (CD166), a cell adhesion molecule (Fig. 5B) . At the same time, there was increased expression of an integrin subunit for cell adhesion (α2-integrin of CD49b), and a protein associated with suppression of metastases (CD82) (Fig. 5B) . As expected from microarray results, assays by flow cytometry also demonstrated a decrease of spheroid hMSCs in S-phase compared with monolayer hMSCs (Fig. S7 A-D) .
Spheroid hMSCs Secrete Antiinflammatory Proteins. Spheroids of hMSCs plated on adherent culture surfaces gradually generated spindle-shaped cells that migrated away from the spheroids (Fig.  6B) . No migration was seen with spheroids plated on nonadherent surfaces (Fig. 6B) . ELISAs demonstrated that hMSCs either in spheroids or dissociated from spheroids continued to secrete TSG-6, STC-1, and LIF when plated on culture dishes for 24 h (Fig.  6 C-E) . The levels of all three factors were much higher than with adherent monolayer hMSCs. About the same levels of STC-1 and LIF were observed in spheroids cultured directly either on adherent or nonadherent plates, but spheroids cultured on nonadherent dishes secreted more TSG-6 ( Fig. 6 C-E) . The levels of TSG-6, STC-1, and LIF decreased when the hMSCs were dissociated from spheroids and cultured on adherent plates but the levels remained much higher than with adherent monolayers (Fig. 6 C-E).
Spheroid hMSCs Decrease Activation of Macrophages in Vitro and
Inflammation in Vivo. The increased secretion of antiinflammatory molecules TSG-6 and STC-1 by the spheroid hMSCs suggested that the cells would be more effective than adherent monolayer cultures of hMSCs in reducing inflammatory responses. To test this prediction, mouse macrophages were preactivated with LPS in the upper chamber of a transwell, followed by a transfer of the chamber to a test well (Fig. 7A) . Under the conditions of the experiment, the presence in the test well of hMSCs from adherent monolayers had no significant effect on the expression or secretion of TNFα by the stimulated macrophages ( Fig. 7B and Fig. S8A ). In contrast, TNFα expression and secretion was decreased significantly by the presence in the test well of intact spheroids or hMSCs dissociated from spheroids ( Fig. 7B and Fig.  S8A ). The results indicated therefore that the spheroid derived hMSCs secreted more effective antiinflammatory factors.
To test the effects of spheroid hMSCs on inflammation in vivo, a mouse model of zymosan-induced peritonitis was used (26). Six hours after i.p. administration of monolayer, spheroid, or spheroid derived hMSCs, inflammatory exudates were collected and used in estimating the level of inflammation. hMSC spheroids significantly decreased the protein content of the lavage fluid ( Fig.  S8B ) and the volume (Fig. S8C ), neutrophil activity, as assayed by secreted myeloperoxidase (MPO) (Fig. 7D) , and levels of the proinflammatory molecules TNFα (Fig. 7C ), IL-1β (Fig. S8D ), CXCL2/MIP-2 ( Fig. S8E ), and PGE 2 ( Fig. 7E ). In addition, serum levels of plasmin activity, an inflammation associated protease that is inhibited by TSG-6 (16), were decreased significantly by hMSC spheroids (Fig. 7F ). Serum plasmin activity was reduced approximately to the levels of noninflammatory control animals 24 h after spheroid injection (Fig. 7F ). Spheroid-derived hMSCs also substantially decreased levels of the inflammatory markers assayed, although to a lesser extent than intact spheroids ( Fig. 7 C-F and Fig. S8 B-E). Moreover, hMSC spheroids were significantly more effective than adherent monolayer hMSC in suppressing inflammation ( 
Discussion
Classically hMSCs were isolated and expanded as adherent monolayer cultures, but it was soon recognized that centrifugation of the cells to form micropellets or large aggregates greatly enhanced their chondrogenic differentiation that slowly occurred over several weeks (18, 27). However, several recent publications demonstrated that culture of MSCs in 3D or as spheroids for shorter periods of time improved their therapeutic potential by increased expression of genes such as CXCR4 to promote adhesion to endothelial cells or of IL-24 that has tumor suppressing properties (20, 22, 23) . The experiments presented here were designed to prepare hMSCs as spheroids that maximally expressed TSG-6, the antiinflammatory protein that produced beneficial effects in mice with myocardial infarcts because it was expressed at high levels after i.v.-infused hMSCs were trapped in the lung (14) .
The results demonstrated that the properties of hMSCs cultured as spheroids depend critically on the experimental conditions. In hanging drops, the cells first formed a network and then most of the cells coalesced into a single spheroid. Optimal levels of TSG-6 expression were observed with spheroids approximately 500 μm in diameter and incubated for 3 d. Expression levels remained high but were lower in larger spheroids, and more of the cells became apoptotic or necrotic in the larger spheroids. Also, more of the cells became apoptotic or necrotic with longer times of incubation. The cells in spheroids retained most of the surface epitopes of hMSCs from adherent cultures. Also, hMSCs dissociated from spheroids retained the potential to differentiate into mineralizing cells and adipocytes. They also expanded at a similar rate as hMSCs from adherent monolayer cultures after a delay through one passage. In addition, spheroiddissociated hMSCs remained highly clonogenic.
As was observed previously with large hMSC spheroids (28) and hMSCs in 3D culture (22), surveys with mRNA/cDNA microarrays demonstrated marked differences in the transcriptomes compared with hMSCs from adherent cultures. Quantitative assays confirmed some of the important differences. As expected, there was a marked decrease in the anticell-adhesion protein PODXL (24) and a decrease in cell cycling. Of special note was that several of the differences had important implications for the potential therapeutic uses of hMSCs. There were higher levels of expression of the antiinflammatory protein TSG-6 than previously observed by preincubation of hMSCs with TNFα (14) . Also, there was a high level of expression of STC-1, a protein with both antiinflammatory and antiapoptotic effects (13, 29) . The high levels of expression of both TSG-6 and STC-1 were maintained for at least 1 d after the cells were dissociated from the spheroids. Therefore the results suggested that both spheroids and spheroid derived hMSCs may be more effective than hMSCs from adherent cultures in modulating inflammatory reactions. The suggestion was confirmed by the demonstration that the spheroids and spheroid derived hMSCs were more effective in suppressing TNFα production by LPS stimulated macrophages in culture. In addition, they were more effective in suppressing inflammation in an in vivo model for zymosan induced peritonitis. Also of special interest was that the spheroid hMSCs expressed high levels of transcripts for the tumor suppressor protein IL-24, an observation made previously with 3D cultures of hMSCs prepared using spinner flasks and a rotating wall vessel bioreactor (22). In addition, the spheroid hMSCs prepared under the conditions optimized to express TSG-6 also expressed high levels of transcripts for TRAIL that is selective for killing certain cancer cells (30, 31) and for CD82 that suppresses some metastases (32). Therefore, spheroids and spheroid derived hMSCs may be particularly effective as an adjunct therapy for some types of cancers, particularly for therapy of cancers sensitive to antiinflammatory agents such as aspirin or steroids (33). A further advantage of the spheroid hMSCs was that they were less than one-fourth the volume of hMSCs from adherent cultures. Therefore a significantly smaller number was trapped in the lung after i.v. infusion and thus larger numbers were found in many tissues (14, 24) .
The molecular forces that increase expression of antiinflammatory and antitumorigenic genes in hMSCs assembled into spheroids are intriguing but unclear. Cells in spheroids are in NOD/scid mice were infused i.v. with 10 6 monolayer or spheroid derived hMSCs. After 15 min, tissues were harvested for genomic DNA and tissue distribution of hMSCs was determined with real-time PCR for human Alu and GAPDH (n = 4-5) and shown as relative to Adh High sample. *P < 0.05, **P < 0.01, and ***P < 0.001. Values are mean ± SD. Abbreviations: as in Fig. 1 . close association with each other and probably signal cues to each other much easier than in monolayer cultures, where only a very small part of the cell can touch another cell and secreted molecules must be present in high amounts to ensure communication. The changes in the hMSCs as they form spheroids are probably the result of the nonadherent culture conditions, high degree of confluency, nutrient deprivation, air-liquid interface, and "microgravity" of hanging drops. More detailed studies of each of these and other possible factors must be conducted to have a better understanding of the changes hMSCs accrue when they aggregate into spheroids.
The results presented here indicated that hMSCs can be activated nonchemically in hanging drops to secrete substantial quantities of potent antiinflammatory proteins and express antitumorigenic molecules. Therefore spheroid hMSCs may have advantages for many therapeutic applications. In addition, hMSCs dissociated from spheroids provide extremely small activated cells that could have major advantages for i.v. administration.
Materials and Methods
More detailed methods are presented in the SI Materials and Methods.
hMSC Cell Culture. Frozen vials of passage 1 hMSCs from bone marrow were obtained from the Center for the Preparation and Distribution of Adult Stem Cells (http://medicine.tamhsc.edu/irm/msc-distribution.html). After 24-h recovery, hMSCs were seeded at low density (100 cells/cm 2 ), and incubated in complete culture medium (CCM) containing 17% FBS for 7-8 d until approximately 70% confluent. hMSCs were passed under the same conditions through no more than three passages before being used for assays.
Spheroid Generation and Dissociation. hMSCs were plated in hanging drops in 35 μL of CCM containing 10,000-250,000 cells/drop for up to 4 d. To obtain spheroid derived cells, spheroids were incubated with trypsin/EDTA for 5-30 min (depending on the size of the spheroid) while pipetting every 2-3 min.
Intravenous Infusion of hMSCs and Alu PCR. Male NOD/scid mice were infused with 10 6 monolayer or spheroid derived hMSCs i.v. followed by collection of tissues 15 min later. Genomic DNA was isolated and used to determine the relative quantity of human DNA in each tissue with real-time PCR for human Alu and GAPDH and mouse GAPDH (14, 24, 34) .
Mouse Model of Peritonitis and Measurements of Inflammation. To induce inflammation in male C57BL/6J mice, zymosan solution was administered i.p., followed by i.p. injection of either 1.5 × 10 6 monolayer hMSCs, 1.5 × 10 6 spheroid derived cells, or 60 spheroids 15 min later. After 6 h, inflammatory exudates were collected by peritoneal lavage and the cell-free supernatant was used to measure total protein, neutrophil activity (secreted mMPO), and levels of the proinflammatory molecules mTNFα, mIL-1β, mCXCL2/MIP-2, and PGE 2 . Twenty-four hours after cell injection, blood was collected from the right ventricle and the mouse plasmin activity was measured from the serum.
ACKNOWLEDGMENTS. This work was supported in part by National Institutes of Health Grants P01HL075161, R01HL073755, and P40RR17447. C57BL/6 mice were injected i.p. with zymosan to induce inflammation. After 15 min, the mice were injected i.p. with 1.5 × 10 6 monolayer hMSCs, 60 spheroids, or 1.5 × 10 6 spheroid derived cells. After 6 h, peritoneal lavage was collected and mTNFα (C), mMPO (D), and PGE 2 (E) levels were determined with ELISAs. Total amounts of the specific molecules in the lavage are shown (n = 4-8). After 24 h, blood was collected and plasmin activity was measured from serum (n = 3-6). Values are mean ± SD. Not significant (NS) P ≥ 0.05, *P < 0.05, **P < 0.01, and ***P < 0.001. Abbreviations: as in Figs. 1 hMSCs were isolated from 1-4 mL bone marrow aspirates of the iliac crest in normal adult donors. Nucleated cells, obtained by density gradient centrifugation (Ficoll-Paque; GE Healthcare), were resuspended in CCM: α-MEM (Gibco), 17% FBS (Atlanta Biologicals), 100 units/mL penicillin (Gibco), 100 μg/mL streptomycin (Gibco), and 2 mM L-glutamine (Gibco), seeded in 175 cm 2 flasks (Nunc), and subsequently cultured at 37°C in a humidified atmosphere with 5% CO 2 . After 24 h, nonadherent cells were discarded. Adherent cells were incubated 4-11 d until approximately 70% confluent, harvested with 0.25% trypsin and 1 mM EDTA (Gibco) for 5 min at 37°C, and replated at 50 cells/ cm 2 in an intercommunicating system of culture flasks (Nunc). The cells were incubated for 7-12 d until approximately 70% confluent, harvested with trypsin/EDTA, and frozen as passage 1 cells in α-MEM containing 30% FBS and 5% DMSO (Sigma). A frozen vial of passage 1 hMSCs (donor 1, 7064 L; donor 2, 7068 L) was thawed, resuspended in CCM, and plated in a 152-cm 2 culture dish (Corning). After 24 h, adherent cells were harvested using trypsin/EDTA, plated at 100 cells/cm 2 , and expanded for 7 d before freezing. In this study, passage 1 or 2 frozen hMSCs were recovered, seeded at 100 cells/cm 2 24 h later, and grown 7-8 d in CCM for various assays.
Spheroid Generation and Dissociation. To generate spheroids, hMSCs were plated as hanging drops on an inverted culture dish lid in 35 μL of CCM at 10,000-250,000 cells/drop. The lid was flipped and placed on a culture dish containing PBS (Gibco) to prevent evaporation. Hanging drop cultures were grown at 37°C up to 4 d in a humidified atmosphere with 5% CO 2 . Spheroid generation in hanging drops was captured using a Photometrics Coolsnap HQ2 camera mounted on a Nikon Eclipse Ti-E inverted microscope containing a temperature controlled environmental chamber. To collect spheroids, drops were harvested using a cell lifter, transferred to a 15 or 50 mL conical tube (Falcon), washed with PBS, and centrifuged at 453 × g for 5-10 min. To obtain spheroid derived cells, spheroids were incubated with trypsin/EDTA at 37°C for 5-30 min (5 min for 10k, 10 min for 25k, 20 min for 100k, and 30 min for 250k spheroids), while pipetting every 2-3 min. When no cell aggregates were visible, spheroid derived cells were collected by centrifugation at 453 × g for 5-10 min to be used in described assays.
Histology. hMSC spheroids were collected with cell lifter (Corning), transferred into a 15-mL conical tube, washed twice with PBS, and fixed with 2% paraformaldehyde (USB Corporation) in PBS for 15 min at room temperature. Fixed spheroids were washed twice with PBS, centrifuged at 500 × g for 10 min, and incubated at 4°C overnight in 500 μL of 30% sucrose solution (Sigma) in 0.1 M phosphate buffer (Sigma). After incubation, 800 μL of 30% OCT (Sakura Finetek) in sucrose solution was added gently and the suspension was transferred into a histology mold. The mold was frozen in isopentane (Sigma) chilled by liquid nitrogen and stored at −80°C. Cryosections (6 μm) were prepared with a Microm HM560 cryostat. For H&E staining, slides were first incubated at room temperature for 10-15 min, fixed in 4% PFA for 15 min, and washed twice with deionized water. Rehydration was performed by incubating the samples in 100% ethanol (EMD Chemical) for 5 min, 95% ethanol for 2 min, 70% ethanol for 2 min, and deionized water twice for 5 min. The slides were stained with Mayer's Hematoxylin (Electron Microscopy Science) for 15 min, rinsed with deionized water, incubated with Scott's Tap Water Substitute (Ricca Chemical Company) for 2 min, rinsed with deionized water, washed with warm tap water for 20 min, rinsed with deionized water, immersed in 95% ethanol for 1 min, and stained with Eosin Y (Mallinckrodt Baker) for 1 min. Slides were then dehydrated by immersion in 95% ethanol for 1 min, 95% ethanol for 5 min, 100% ethanol for 5 min, and xylene (EMD Chemical) for 5 min. Samples were air-dried and overlaid with coverslips for examination. Mounting media (VECTA Mount; Vector Laboratories) was used to preserve staining. Images were acquired on a Nikon Eclipse 80i upright microscope and processed using NiS Elements AR 3.0 software (Nikon).
Real-Time RT PCR Assays. Total RNA was isolated from monolayer and spheroid hMSCs using RNeasy Mini Kit (Qiagen) with DNase (RNase-Free DNase Set; Qiagen) digestion step. RNA was converted into cDNA with High-Capacity cDNA RT Kit (Applied Biosystems). Real-time RT PCR was performed in triplicate for 18 s, TSG-6 (TNFAIP6), STC1, LIF, IL-24, TRAIL, CXCR4, and DKK1 using Taqman Gene Expression Assays (Applied Biosystems). A total of 15-60 ng of cDNA was used for each 20-μL reaction. Thermal cycling was performed with 7900HT System (Applied Biosystems) by incubating the reactions at 95°C for 20 s followed by 40 cycles of 95°C for 1 s and 60°C for 20 s. Data were analyzed with Sequence Detection Software V2.3 (Applied Biosystems) and relative quantities (RQs) were calculated with comparative C T method using RQ Manager V1.2 (Applied Biosystems). If no amplification occurred, C T value of 35 was used in calculating the RQs.
Viability Assays. Spheroid viability was measured by flow cytometry (FC500; Beckman Coulter) using Annexin V-FITC apoptosis detection kit (Sigma) per manufacturer's instructions. Spheroids were collected and washed in PBS, followed by debris removal with a 40-μm cell strainer (Fisher). Spheroids were then transferred into a sterile centrifuge tube by inversion of the strainer and subsequently pelleted by centrifugation at 453 × g for 5 min. The supernatant was aspirated and the spheroids dissociated in a six-well plate (Corning) at 37°C using 2-3 mL trypsin/EDTA. After 5-30 min, the digest was neutralized with FBS, filtered through a 40 μm cell strainer to remove nondissociated particles, and centrifuged at 453 × g for 5-10 min to acquire a cell pellet. Approximately 200,000 hMSCs derived from monolayer cultures or spheroids were incubated for 10 min with 0.5 μg/mL annexin V-FITC and 2 μg/mL PI in 400 μL of 1× binding buffer (10 mM Hepes, 0.14 M NaCl, 2.5 mM CaCl 2 ). The cells were immediately placed on ice and analyzed. Cell fragments were removed by morphological gating. Cells negative for annexin V-FITC and PI were considered viable, annexin V-FITC positive and PI negative considered apoptotic, and annexin V-FITC positive and PI positive considered necrotic.
Cell Cycle Analysis. The cell cycle distribution in spheroids and monolayer cultures was determined by analyzing DNA content of permeabilized hMSCs labeled with propidium iodide (Sigma). hMSCs derived from monolayer or spheroid cultures were resuspended in 1 mL of ice cold PBS containing 2% FBS followed by fixing with 3 mL cold absolute ethanol added dropwise while vortexing. The cells were incubated for 2-4 h in 4 mL of 75% ethanol to complete fixation, washed 3 times in PBS, then pelleted by centrifugation at 800 × g for 10 min. Cells were incubated with 7 U/mL RNase A (Qiagen) in 1 mL of PBS at room temperature. After 1 h, 50 μg/mL propidium iodide was added and the cells were incubated overnight at 4°C. DNA content was measured with a flow cytometer and data analyzed using MultiCycle software (Phoenix Flow Systems).
Cell Surface Protein Detection. To analyze cell surface markers, hMSCs resuspended at 3.0 × 10 6 cells/mL in αMEM containing 2% FBS were labeled with the antibodies described (Table S1) for 40 min on ice. The cells were washed 3 times with PBS and surface expression of proteins was determined with a flow cytometer.
Spheroid-Derived Cell Sizing. The size of hMSCs derived from adherent monolayers, or from dissociated spheroids suspended for 3 d in hanging drops at 10,000, 25,000, 100,000, and 250,000 cells/drop, was determined by microscopy and flow cytometry. For microscopic analysis, the cells were transferred into chambers of a Neubauer improved disposable hemocytometer and images captured on a Nikon Eclipse Ti-S inverted microscope using a DsFi1 camera (Nikon). Cell diameter of more than 50 cells per group was subsequently determined using NIS-Elements AR 3.0 software. For flow cytometric analysis of cell size, 2.0 × 10 5 hMSCs were resuspended in 400 μL αMEM containing 2% FBS then incubated for 20 min with 100 nM of the live cell viability dye calcein AM (Molecular Probes) and 10 min with 2 μg/mL of the dead cell nuclear label 7AAD (Sigma). Cell sizes were estimated from the viable population (Calcein + /7AAD − ) by comparing forward scatter (FS) properties of the cells and beads with a known diameter of 3, 7, 15, or 25 μm. Brackets were subsequently applied to the scatter plot at locations corresponding to the respective bead size. Gates established based on bead size FS were used to group the cells into five populations (<3 μm, 3-7 μm, 7-15 μm, 15-25 μm, and >25 μm).
Intravenous Infusion of hMSCs. Male immunodeficient NOD/scid mice (NOD.CB17-Prkdcscid/J; The Jackson Laboratory), 7-8 wk of age, housed on a 12 h light/dark cycle, were used to study the relative tissue distribution of the i.v. infused hMSCs. All animal procedures were performed with approval by the Animal Care and Use Committee of Texas A&M Health Science Center and in accordance with guidelines set forth by the National Institutes of Health. Mice were anesthetized by i.p. injection of a mixture of ketamine (91 mg/kg) and xylazine (9 mg/kg). Total of 10 6 monolayer or spheroid derived hMSCs suspended in 150 μL of HBSS were infused slowly into a tail vein. Mice were anesthetized 15 min later with ketamine/xylazine (90 mg/kg and 9 mg/kg) and euthanized by exsanguination. Heart, lung, liver, spleen, and kidneys were isolated by dissection and stored at −80°C for further analysis.
Isolation of Genomic DNA. After thawing the tissues, 5 mL of 10 mM Tris HCl (pH 8.0) containing 20 μL proteinase K (10 mg/mL), 0.1 mM EDTA (pH 8.0), 0.5% SDS, and 20 μg/mL RNase A was added to each sample. Samples were homogenized (PowerGen Model 125 Homogenizer; Fisher Scientific) and incubated at 50°C overnight on a shaker at 200 rpm. DNA was extracted by mixing 0.5 mL of sample with 0.5 mL phenol/chloroform solution (pH 6.7) followed by centrifugation at 15,300 × g for 5 min in 2 mL phase lock gel tubes (Phase Lock Gel; Eppendorf/Brinkmann Instruments). To precipitate the DNA, 1/2 volume of 2.5 M ammonium acetate, and the same volume of 100% ethanol was added, followed by overnight incubation at 4°C. The precipitates were washed with ice cold 75% ethanol and resuspended into sterile water.
Real-Time PCR Assays for Alu Sequences. Real-time PCR assays for Alu sequences were performed in 50 μL containing 25 μL Taqman Universal PCR Master Mix (Applied Biosystems), 900 nM each of the forward and reverse primers, 250 nM TaqMan probe, and 200 ng of genomic DNA. Reactions were incubated at 50°C for 2 min and at 95°C for 10 min followed by 40 cycles at 95°C for 15 s and 60°C for 1 min. Real-time PCR assays for human and mouse GAPDH genes were performed in 50 μL containing 25 μL SYBR Green Master Mix (Applied Biosystems), 200 nM each of the forward and reverse primers and 200 ng of genomic DNA. All real-time PCR assays were performed in duplicate or triplicate and average values are presented. The final value for total DNA in the sample was corrected by parallel real-time PCR assays with primers that amplified both the human and mouse GAPDH genes. CFU-F assays. hMSCs derived from high density monolayer or hanging drop cultures were seeded onto 55 cm 2 dishes at 1.5 cells/cm 2 in quadruplicate and cultured for 14 d in CCM. Medium was changed every 3-4 d. After 14 d, the plates were stained with 3% crystal violet (Sigma) in 100% methanol (Sigma) for 5 min, washed with water, and air-dried. Plates were scanned on an EPSON Perfection 4490 Photo scanner and images were processed with Adobe Photoshop CS3.
Microarrays. hMSCs from two donors grown at low density for 7 d and at high density or in hanging drops for 3 d were harvested for total RNA. A total of 2 μg of RNA from each sample was applied for microarrays using Whole Transcript Sense Target Labeling Assay protocol (Affymetrix) according to manufacturer's directions. Briefly, to minimize the background and thereby increasing the array detection sensitivity and specificity, rRNA reduction was performed for samples containing the Poly-A RNA controls (GeneChip Eukaryotic Poly-A RNA-Control Kit; Affymetrix) using the RiboMinus Transcriptome Isolation Kit (Invitrogen) with Magna-Sep Magnetic Particle Separator (Invitrogen) and Betaine (Sigma). RNA was concentrated with GeneChip IVT cRNA Cleanup Kit (Affymetrix) and used to prepare double stranded cDNA with GeneChip WT cDNA Synthesis Kit (Affymetrix). Generated cDNA was used to produce cRNA with GeneChip WT cDNA Amplification Kit (Affymetrix), followed by cleanup with GeneChip Sample Cleanup Module (Affymetrix). The amount of cRNA was determined with spectrophotometer (SmartSpec Plus; Bio Rad) and 10 μg was used to generate cDNA with GeneChip WT cDNA Synthesis Kit (Affymetrix) followed by cRNA hydrolysis and cleanup of single-stranded cDNA with GeneChip Sample Cleanup Module. The amount of cDNA was determined with spectrophotometer and 5.5 μg was used for fragmentation with GeneChip WT Terminal Labeling Kit (Affymetrix). The fragmented cDNA was labeled using GeneChip WT Terminal Labeling Kit and hybridized (GeneChip Hybridization Oven 640; Affymetrix) on Human Exon 1.0 ST arrays (Affymetrix) using GeneChip Hybridization, Wash, and Stain Kit (Affymetrix). Arrays were washed and stained (GeneChip Fluidics Station 450; Affymetrix) using GeneChip Hybridization, Wash, and Stain Kit followed by scanning with GeneChip Scanner (Affymetrix). Data were normalized using robust multiarray (RMA) algorithm and gene level analysis was performed with Partek Genomics Suite 6.4 (Partek). Genes that were either up-or downregulated in spheroids at least twofold, compared with their monolayer counterparts, were used in hierarchical clustering. Significant Gene Ontology terms for up-and down-regulated genes in spheroids were determined using the Partek software. The raw microarray data files will be available at the Gene Expression Omnibus website (http://www.ncbi.nlm.nih.gov/geo/).
Analysis of hMSC-Secreted Soluble Antiinflammatory Factors. For TSG-6, STC-1, and LIF ELISAs, monolayer, spheroids, and spheroid-derived hMSCs were seeded at equal cell density (200,000 cells/well or 8-25k spheroids/well) on tissue-culture treated sixwell dishes in 1.5 mL of CCM. In addition, hMSC spheroids were also suspended at 8 spheroids/well on nonadherent six-well dishes (Corning). After 24 h, images were acquired, conditioned medium was collected, and the cells were lyzed with 100 μL of modified RIPA buffer containing HALT protease/phosphatase inhibitors (Thermo Scientific). Conditioned medium was cleared of cellular material by centrifugation at 500 × g for 10 min and stored at −80°C. Total cellular protein was measured in whole cells lysates using the bicinchoninic acid (BCA)-dependent colorimetric detection method (Micro BCA Protein Assay Kit; Thermo Scientific). Human TSG-6 protein levels in conditioned medium were determined by ELISA as described (1) with some modifications. Briefly, wells of microplate strips (Costar) were coated overnight at 4°C with 10 μg/mL TSG-6-specific monoclonal antibody (clone A38.1.20; Santa Cruz Biotechnology, Inc.) in 50 μL of 0.2 M bicarbonate buffer (pH 9.2). The plates were washed 3 times with 400 μL of 1× wash buffer (R&D Systems), blocked with 100 μL of 1× PBST (Cell Signaling) containing 0.5% BSA (Thermo), and incubated for 2 h with 50 μL of sample or recombinant human TSG-6 protein standards (R&D Systems) diluted in blocking buffer. Wells were subsequently washed and incubated with 0.5 μg/mL biotinylated antihuman TSG-6 (R&D Systems) in 50 μL of 1× PBST. After 2 h, the samples were incubated for 20 min with 50 μL of streptavidin-HRP (R&D Systems), then with 100 μL substrate solution (R&D Systems). The colorimetric reaction was terminated after 15 min with 2 N sulfuric acid (R&D Systems) and the optical density determined on a plate reader (FLUOstar Omega; BMG Labtech) at an absorbance of 450 nm with wavelength correction at 540 nm. Human STC-1 and LIF proteins were detected with commercially available ELISA kits (R&D Systems) following procedures described by the manufacturer. Two hundred μL of sample/well was used for the LIF ELISA and 100 μL for the STC-1 ELISA. The obtained values were normalized to total cellular protein content to account for loss of cell/spheroid transfer.
Macrophage Inflammatory Assay. J774A.1 mouse macrophages (ATCC) were cultured on 15-cm bacteriological dishes (Falcon) in high glucose DMEM (Invitrogen) supplemented with glutamax, 10% FBS, and penicillin/streptomycin. Subcultures were prepared by washing the cells from the dish every 2-3 d and replating at a ratio of 1:5 to 1:10. For the inflammatory assay, macrophages (MФ) were seeded in the upper chamber of a 24-mm transwell insert with 0.4-μm pores (Corning) at 400,000 cells/well followed by stimulation with 0.1 μg/mL of LPS (Sigma). After 90 min, LPS was removed and the cultures replaced with fresh medium. Total of 200,000 monolayer hMSCs, 200,000 spheroid derived cells, or 8-25k spheroids were transferred to the plate beneath the transwell. After 5 h, medium conditioned by the macrophages was collected and clarified by centrifugation at 500 × g for 10 min. A total of 50 μL of conditioned medium was used for mTNFα ELISA (Quantikine Kit; R&D Systems). Mouse macrophages were washed with PBS and harvested for RNA to quantify mTNFα expression levels by Real-time RT PCR using Taqman Gene Expression Assay.
Mouse Model of Peritonitis. Male C57BL/6J mice (Jackson Laboratories), 6-8 wk of age and housed on a 12 h light/dark cycle, were used to study the antiinflammatory action of hMSC spheroids on zymosan-induced peritonitis. All animal procedures were performed with approval by the Animal Care and Use Committee of Texas A&M Health Science Center and in accordance with guidelines set forth by the National Institutes of Health. The inflammatory compound Zymosan A (Sigma) was prepared at a concentration of 1 mg/mL in PBS and autoclaved for 15 min to sterilize. To induce inflammation, 1 mL of the 0.1% zymosan solution was administered i.p. Fifteen minutes later, either 1.5 × 10 6 monolayer hMSCs, 1.5 × 10 6 spheroid derived cells, or 60-25k spheroids were administered i.p. through a 20-gauge needle or catheter in 150-200 μL of HBSS (Gibco). After 6 h, animals were killed by cervical dislocation and the exudates retrieved by peritoneal lavage using 1.5 mL sterile PBS, pH 7.4, containing a 1× concentration of Halt protease inhibitors (Thermo Scientific) and 5 mM EDTA (Thermo Scientific). The lavage volume was recorded and the cells removed by centrifugation at 500 × g for 10 min. The protein-rich supernatants were then transferred to fresh microcentrifuge tubes, cleared of debris by centrifugation for 10 min at 10,000 × g, and stored at −80°C. Amounts of peritoneal exudation were determined by subtracting the measured lavage volume of each sample from the averaged baseline volume. Twenty-four hours after cell delivery, blood was collected from the right ventricle of anesthetized mice and transferred to Capiject clot activating tubes (Terumo Medical Corporation). The tubes were inverted 8-10 times and incubated at room temperature for 20-30 min to facilitate clot formation. The samples were centrifuged at 1500 × g for 10 min and the serum layer collected for measurements of plasmin activity.
Measurements of Inflammation in Peritoneal Exudates and Blood
Serum. Levels of inflammatory molecules TNFα, IL-1β, CXCL2/ MIP-2, and PGE 2 were determined from the peritoneal lavage using commercially available ELISA kits (R&D Systems). Fifty microliters of sample per well was used for the detection of TNFα, 25 μL for IL-1β (1:2 dilution), 6.7 μL for CXCL2 (1:7.5 dilution), and 3 μL for PGE 2 (1:50 dilution). Secreted myeloperoxidase (MPO), a marker of neutrophil activity, was measured from the cell-free lavage fluid with a mouse-specific MPO ELISA kit (Hycult Biotech) per manufacturer's instructions. Total protein was evaluated with the Micro BCA protein detection kit (Thermo Scientific). Serum plasmin activity, a marker of inflammatory status, was ascertained by measuring time dependent cleavage of the chromogenic substrate Chromozym PL (Roche Applied Science) into 4-nitranline in 50 mM Tris-HCl (pH 7.4) and 0.9% NaCl. Brackets were applied to the scatter plot at locations corresponding to the appropriate bead size (I = 0, J = 3 μm, K = 7 μm, L = 15 μm, and M = 25 μm). Assays were performed at the same voltages. . MΦs were seeded in the upper chamber of a transwell, stimulated with LPS for 90 min, the LPS was removed, and the chamber transferred to a six-well dish plated with monolayer (Adh), spheroid (Sph), or spheroid derived (Sph DC) hMSCs at equal cell density. MΦ:hMSC (2:1). After 5 h, MΦs were lyzed, RNA was isolated, and mTNFα expression was determined with real-time RT PCR. Values are mean ± SD (n = 3) normalized to MΦ sample without LPS stimulation. (B-E) Antiinflammatory activity of hMSCs in a mouse model of peritonitis. C57BL/6 mice were injected i.p. with zymosan to induce inflammation. After 15 min, the mice were injected i.p. with 1.5 × 10 6 monolayer hMSCs (Adh), 60 spheroids (Sph), or 1.5 × 10 6 spheroid derived cells (Sph DC). After 6 h, peritoneal lavage was collected and lavage protein content (B), volume (C), mIL-1β (D), and mCXCL2 were determined. Values are mean ± SD (negative control, n = 4; vehicle control, n = 6; Adh treated, n = 6; Sph treated, n = 8; Sph DC treated, n = 6). Not significant (NS) P ≥ 0.05, *P < 0.05, **P < 0.01, and ***P < 0.001. 
